|
|
Africa/Middle East
Abbott Slashes HIV Drug Price For Developing Nations
Tuesday, August 15, 2006
Still struggling with how to protect its patent rights, drug maker Abbott Laboratories Inc. has said it will launch new initiatives aimed at expanding the availability of its new HIV medicine in the developing world. |
Erbitux Trial Awaits Judge’s Decision
Friday, July 21, 2006
After hearing closing arguments on Wednesday, a Manhattan district court judge must now decide whether three Israeli scientists should be named co-inventors of the blockbuster cancer drug Erbitux. |
AstraZeneca Sues Generic Drug Maker Over Prilosec
Thursday, June 01, 2006
Swedish-U.K. drug manufacturer AstraZeneca AB has fired off a lawsuit to block an Israeli company from making a generic version of its gastrointestinal treatment drug Prilosec OTC. |
WHO To Probe Global Drug Patent System
Tuesday, May 30, 2006
Amid growing criticism that poor nations are being denied access to crucial medicines, vaccines and diagnostic tests, the World Health Organization said it plans to review whether the international drug patent system curbs the ability of developing countries to obtain patented medical treatments. |
Merck Revives Spat With Teva Over Fosamax
Thursday, May 11, 2006
In a long-simmering patent dispute over blockbuster osteoporosis drug Fosamax, Merck & Co. is striking back at Israeli generic maker Teva Pharmaceuticals, saying Teva garnered a Federal Circuit victory last year by withholding one of its own patent applications in a move Merck is calling a “grave miscarriage of justice.” |
Movie Studios' New Piracy Losses Questioned
Wednesday, May 03, 2006
A two-year study of global movie piracy, which included illegal Internet downloads for the first time, has revealed stunning financial losses for the U.S. movie industry, but some experts question the accuracy of the data that will be used as a “roadmap” to fight piracy worldwide. |
IP Blacklist Points To China and Russia
Monday, May 01, 2006
China and Russia topped the list as the most serious offenders of intellectual property laws and enforcement, according to the U.S. Trade Representative’s “Special 301” report to Congress. |
WIPO Adopts Global Trademark Treaty In Singapore
Wednesday, March 29, 2006
Marking what industry professionals say is a milestone in global trademark regulation, a new international treaty on trademarks has been adopted by a group of intellectual property rights experts and member states of the United Nations’ World Intellectual Property Organization. |
WIPO Aims To Revise Global Trademark Rules
Wednesday, March 15, 2006
Intellectual property rights experts meeting at the United Nations’ World Intellectual Property Organization conference in Singapore are revising a global trademark treaty, with plans to introduce electronic filing processes and define trademark protection for such non-traditional items as holograms, sounds and smells. |
Abbott Bids To Toss Antitrust Charges Over TriCor
Wednesday, March 15, 2006
A persistent legal battle plagues Abbott Laboratories one year after the company resolved a patent dispute with Israeli drug maker Teva Pharmaceutical Industries Ltd., which has accused Abbott of antitrust violations over its blockbuster cholesterol treatment TriCor. |
Teva Shoots Back With Suit Against Pfizer
Friday, February 17, 2006
Israeli generics maker Teva Pharmaceutical Industries Ltd. fired off a lawsuit Friday in an attempt to counter claims that it had violated patent laws regarding the production of a popular antibiotic called azithromycin—a generic version of the Pfizer Inc.-developed drug Zithromax. |
Rival Calls For Shutdown of Google Earth
Monday, January 09, 2006
A Virginia-based software company is calling for the shutdown of a key part of Google’s popular mapping service in a patent dispute that claims Google is infringing on its technology and causing irreparable harm to its sales. |
Honeywell Sued Over Motion-Detecting Device
Monday, December 12, 2005
A small Texas lens manufacturer has filed a lawsuit against technology giant Honeywell International Inc. and other competitors for allegedly infringing patents for motion sensor technology. |
Cephalon, Teva Settle Patent Dispute Over Provigil
Friday, December 09, 2005
Cephalon Inc. and Israeli generic-drug maker Teva Pharmaceutical Industries Ltd. have struck a deal to put an end to their patent disputes involving Cephalon's narcolepsy drug Provigil, the two companies said. |
U.S. Welcomes New WTO Compulsory Licensing Policy
Tuesday, December 06, 2005
The U.S. government put its stamp of approval on new compulsory licensing rules by the World Trade Organization, which dramatically decrease intellectual property barriers faced by developing countries fighting life threatening diseases. |
Teva, Sandoz Launch At-Risk Versions of Pfizer Drug
Tuesday, November 29, 2005
The U.S. Food and Drug Administration has given the green light to three generic drug makers’ plans to market their own versions of Pfizer’s Zithromax antibiotic. Two of the companies have decided to launch at risk versions of the drugs, in an effort to grab lucrative market share. |
WTO Extends Compliance Deadline For Poorest Countries
Tuesday, November 29, 2005
The World Trade Organization has given the world’s poorest countries seven more years to provide protection for intellectual property under the WTO’s statutes, extending the deadline from January 2006 to January 2013. |
Ulcer Drug Patents Spark Court Battle
Tuesday, November 22, 2005
AstraZeneca has responded to Ranbaxy’s attempt to market a generic version of popular ulcer drug Nexium, filing a lawsuit in district court in New Jersey accusing the Indian drug maker of patent infringement. |
J&J Faces New Challenge To Schizophrenia Drug
Wednesday, November 16, 2005
India-based generic drug maker Dr. Reddy’s Laboratories Ltd. has been sued by Johnson & Johnson for attempting to manufacture and sell a generic version of its popular drug for schizophrenia and bipolar I disorder. |
Israel Revamps Drug Patent Extension Policy
Thursday, November 10, 2005
In an unprecedented move expected to align the interests of international pharmaceutical companies, the Israel Patent Office will extend patents in its jurisdiction based on extensions provided in other countries. |
 |
French Tax Raises Money For Drugs—And IP Concerns
As international governments and drug companies struggle to find a balance between protection of intellectual property and the rights of poor nations to access crucial medications, a controversial new French initiative stands to fuel the growing debate by pressuring the pharmaceutical industry to lower its prices. |
|
Latest Articles
London Fog Lets Go Of Trademark
Monday, August 21, 2006
Still selling off its assets, bankrupt rainwear maker London Fog Group Inc. has unloaded its famed trademark, with Iconix Brand Group Inc. snapping up the recognizable brand for $30.5 million in cash and $7 million in stock.
|
No End In Sight In Plavix Battle
Monday, August 21, 2006
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.
|
Lengthy Patent Battle Wages On For Microsoft
Monday, August 21, 2006
Timeline Inc. announced Monday that it has terminated a limited license with Microsoft Corp. for use of its patents with the software giant’s SQL Servers, and has asked a federal court to add Microsoft to a patent infringement lawsuit.
|
eBay Opinion Doesn’t Affect Preliminary Injunctions, Judge Rules
Monday, August 21, 2006
A federal judge has ruled that a landmark Supreme Court decision involving eBay only relates to permanent injunctions and not preliminary ones.
|
Federal Circuit Overturns Jury Verdict Against ACell
Monday, August 21, 2006
The Federal Circuit has overturned a jury verdict that found biotechnology company ACell Inc. liable for patent infringement of a tissue-engineering method for healing wounds and scars, ruling against Cook Biotech Inc. and Purdue Research Foundation.
|
Silicon Graphics To Retain Paul Hastings
Monday, August 21, 2006
Silicon Graphics Inc. has requested permission to hire Paul, Hastings, Janofsky & Walker LLP to act as its special intellectual property counsel.
|
Courts Write History on Permanent Injunctions In Patent Actions
Monday, August 21, 2006
Although a few more pages have been filled on the subject, there are still more pages that need to be written before the full impact and proper manner of applying the logic set forth in eBay will be understood, say Anthony F. Lo Cicero and Charles R. Macedo of Amster, Rothstein & Ebenstein LLP.
|
DexCom Scores Stay, Partial Dismissal In Abbott Suit
Friday, August 18, 2006
DexCom Inc. revealed Friday that it received a favorable ruling in a patent infringement dispute with rival Abbott Diabetes Care Inc. over technology related to glucose monitors used by diabetics.
|
EchoStar Wins Block Of Damaging DVR Injunction
Friday, August 18, 2006
The U.S. Courts of Appeals for the Federal Circuit Friday blocked a temporary injunction that would have prevented Echostar Communication Corp. from selling some of its digitial video recorders and stopped the service of about 4 million DVRs within 30 days.
|
Gloves Come Off In Plavix Battle
Friday, August 18, 2006
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.
|
|
|
